You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

influenza virus

Showing 1 - 25 of 9,514
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Influenza Trial in Taizhou (Quadrivalent influenza virus subunit vaccine, Quadrivalent split influenza virus vaccine)

Not yet recruiting
  • Influenza
  • Quadrivalent influenza virus subunit vaccine
  • Quadrivalent split influenza virus vaccine
  • Taizhou, Jiangsu, China
    Ab&b Biotechnology Co., Ltd.JS
Jan 12, 2023

Influenza Infection Trial (Molnupiravir, Placebo molnupiravir, Placebo oseltamivir)

Not yet recruiting
  • Influenza Infection
  • (no location specified)
Apr 5, 2023

Influenza, Human Trial (Clarithromycin 250 MG, Placebos)

Suspended
  • Influenza, Human
  • Clarithromycin 250 MG
  • Placebos
  • Hong Kong, Hong Kong
    School of Public Health, The University of Hong Kong
Nov 1, 2022

Influenza Virus and Coronavirus in Human Brain Explant Culture

Recruiting
  • Influenza Virus
  • Coronavirus
    • Shatin, NT, Hong Kong
      Prince of Wales Hospital
    Aug 16, 2022

    Influenza, Human Trial in Feicheng City (Quadrivalent Influenza Virus Split Vaccine)

    Recruiting
    • Influenza, Human
    • Quadrivalent Influenza Virus Split Vaccine
    • Feicheng City, Shandong, China
      Tingting and Yu
    Aug 3, 2022

    Zoonotic Influenza Surveillance in Belgium

    Not yet recruiting
    • Influenza, Human
    • respiratory specimen
    • serum
    • (no location specified)
    Apr 12, 2023

    Prevention of Influenza Trial in Changsha (Investigational Vaccine(0.25ml/vial), Investigational Vaccine(0.5ml/vial), Active

    Not yet recruiting
    • Prevention of Influenza
    • Investigational Vaccine(0.25ml/vial)
    • +2 more
    • Changsha, Hunan, China
      Hunan Provincial Center for Disease Control and Prevention
    Dec 6, 2022

    Influenza Virus - A Multicenter Registry

    Completed
    • Influenza Infection in Transplant Patients
      • Edmonton, Alberta, Canada
      • +1 more
      May 26, 2022

      Influenza Infection Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (A/Mallard/Ohio-99/MM4/1989

      Not yet recruiting
      • Influenza Infection
      • A/Mallard/Ohio-99/MM4/1989 H10N7
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 17, 2022

      Influenza Trial in Guangzhou (Inavtivated Quadrivalent Influenza Virus Split Vaccine)

      Active, not recruiting
      • Influenza
      • Inavtivated Quadrivalent Influenza Virus Split Vaccine
      • Guangzhou, Guangdong, China
        Yangchun Center for Disease Control and Prevention
      May 18, 2022

      Influenza Virus Infection Trial in Hunan (TG-1000)

      Completed
      • Influenza Virus Infection
      • Hunan, China
        Xiangya Hospital Central South University
      Mar 8, 2022

      COPD Trial in Chapel Hill (LAIV)

      Not yet recruiting
      • COPD
      • LAIV
      • Chapel Hill, North Carolina
        Eastowne Medical Office Building
      Aug 9, 2022

      Influenza Trial in Atlanta (Influenza Virus Type A H3N2 Challenge)

      Recruiting
      • Influenza
      • Influenza Virus Type A H3N2 Challenge
      • Atlanta, Georgia
      • +2 more
      Jun 27, 2022

      Influenza Prophylaxis Trial in London (INNA-051, Placebo)

      Recruiting
      • Influenza Prophylaxis
      • London, United Kingdom
        hVIVO
      Apr 7, 2022

      Influenza Trial in Wenling (GP681 40mg, Placebo)

      Recruiting
      • Influenza
      • GP681 40mg
      • Placebo
      • Wenling, Zhejiang, China
        The First People's Hospital of Wenling
      Aug 3, 2022

      Acute Respiratory Tract Infections Trial in Hanoi (LiveSpo Navax, 0.9% NaCl physiological saline)

      Completed
      • Acute Respiratory Tract Infections
      • LiveSpo Navax
      • 0.9% NaCl physiological saline
      • Hanoi, Vietnam
        International Center, Vietnam National Children's Hospital
      May 17, 2022

      Influenza Trial in Nanjing (quadrivalent influenza split vaccine, Influenza virus split vaccine)

      Recruiting
      • Influenza
      • quadrivalent influenza split vaccine
      • Influenza virus split vaccine
      • Nanjing, Jiangsu, China
        Jiangsu Province Centers for Disease Control and Prevention
      Mar 29, 2022

      Influenza Trial in Baltimore, College Park (Personal Protective Equipment (PPE) - Under High Air Hygiene, No Intervention -

      Not yet recruiting
      • Influenza
      • Personal Protective Equipment (PPE) - Under High Air Hygiene
      • +3 more
      • Baltimore, Maryland
      • +1 more
      Jan 6, 2023

      Influenza, Influenza Immunisation Trial in Rochester (Influenza Virus Quadrivalent Inactivated Vaccine)

      Completed
      Has Results
      • Influenza
      • Influenza Immunisation
      • Influenza Virus Quadrivalent Inactivated Vaccine
      • Rochester, New York
        University of Rochester Medical Center - Strong Memorial Hospita
      Mar 17, 2022

      Influenza, Human, Infections, Respiratory Tract Infections Trial in Philippines, United States (Low dose A/H2N3c + standard dose

      Not yet recruiting
      • Influenza, Human
      • +4 more
      • Low dose A/H2N3c + standard dose MF59
      • +5 more
      • Rockville, Maryland
      • +7 more
      May 26, 2023

      Influenza, Human Trial (Quadrivalent Influenza Vaccine (split virion, inactivated), Trivalent Influenza Vaccine (split virion,

      Not yet recruiting
      • Influenza, Human
      • Quadrivalent Influenza Vaccine (split virion, inactivated)
      • +2 more
      • (no location specified)
      Mar 9, 2023

      Avian Influenza, H1N1 Influenza, Influenza Trial in Nashville (AS03, Influenza Virus Vaccine, Monovalent A/H3N2v

      Completed
      Has Results
      • Avian Influenza
      • +2 more
      • Nashville, Tennessee
        Vanderbilt University Medical Center - Vanderbilt Institute for
      Jan 25, 2022

      Influenza Trial in Durham (Influenza Virus Quadrivalent Inactivated Vaccine, Sodium Chloride, 0.9%, VRC-FLUNPF099-00-VP

      Not yet recruiting
      • Influenza
      • Influenza Virus Quadrivalent Inactivated Vaccine
      • +2 more
      • Durham, North Carolina
        Duke Human Vaccine Institute - Duke Vaccine and Trials Unit
      Feb 23, 2023

      Nosocomial Influenza Surveillance of 2022 - 2027 Seasonal Period

      Not yet recruiting
      • Infection Viral
      • Influenza-like illness group
      • (no location specified)
      Feb 3, 2023

      Respiratory Viral Infection Trial (SARS-COV-2, Influenza and RSV 8-Well MT-PCR Panel, BioFire Respiratory Panel 2.1)

      Not yet recruiting
      • Respiratory Viral Infection
      • SARS-COV-2, Influenza and RSV 8-Well MT-PCR Panel
      • BioFire Respiratory Panel 2.1
      • (no location specified)
      Jul 13, 2023